SABCS 2023 | Alexandra-Studie: Immuntherapie erst nach der Operation (adjuvant) mit Atezolizumab

Download video

SABCS 2023 | Alexandra-Studie: Immuntherapie erst nach der Operation (adjuvant) mit Atezolizumab

1.9K views

Brustkrebs Deutschland e.V.

1 year ago

SABCS 2023 | Alexandra-Studie: Immuntherapie erst nach der Operation (adjuvant) mit Atezolizumab

2:53

SABCS 2023 | Alexandra-Studie: Immuntherapie erst nach der Operation (adjuvant) mit Atezolizumab

by Brustkrebs Deutschland e.V.

7:33

SABCS 2023 | neoMono Studie: Neoadjuvante Immuntherapie mit Atezolizumab

by Brustkrebs Deutschland e.V.

0:19

SITC Digital workshop

by KCR CRO

0:49

Breast cancer at ESMO 2023: ADCs and MONARCH 3

by VJOncology

$Update from ASCO 2023 – LYMPHOMA \& MYELOMA CONNECT$

2:19

Update from ASCO 2023 – LYMPHOMA \& MYELOMA CONNECT

by COR2ED The Heart of Medical Education

16:28

ESMO 2024: Breast Cancer Highlights with Prof. Ahmad Awada

by Karger Publishers

5:58

Dr. Charles Savoldelli

by Mectron Medical

$TWICE \\$

3:23

TWICE \\"The Feels\\" Choreography Video (Moving Ver.)

by TWICE

2:18

Post-nasal Drip

by ENT health

0:35

SITC Sparkathon 2023

by Society for Immunotherapy of Cancer

0:31

SITC 2024 SCION- Clinical Trial Development Workshop - Application Deadline Extended

by Society for Immunotherapy of Cancer

1:37

#ESMO24 | Le ultime novità sul melanoma | Paolo Ascierto

by AIOM Tv

0:58

Setanaxib and pembrolizumab in head and neck squamous cell carcinoma

by VJOncology

Best on Vidoe

SABCS 2023 | Alexandra-Studie: Immuntherapie erst nach der Operation (adjuvant) mit Atezolizumab